Anson Resources to Commence Drilling at Yellow Cat Uranium-Vanadium Project, Utah USA 
Anzé Mofor Launches Love Better: A Sacred Journey Back to You, A Powerful Guide to Reclaiming Self-Love and Transforming Relationships 
Voghion Reveals A Year Of Global Shopping Events 
QuestDB Supports HDFC Bank’s Real-Time Transaction Monitoring and Risk Analytics PCI Biotech first quarter 2021 interim results
Oslo (Norway), 7 May 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company,…
Bone Therapeutics to host Annual General Meeting on 9 June 2021
REGULATED INFORMATION Preliminary documents for the Annual General Meeting have been made available on company’s…
Talaris Therapeutics Announces Pricing of Initial Public Offering
BOSTON and LOUISVILLE, Ky., May 06, 2021 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc., a late-clinical…
Phathom Pharmaceuticals to Present at the Bank of America Securities 2021 Virtual Healthcare Conference
FLORHAM PARK, N.J., May 06, 2021 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a…
UPDATE – Efferent Labs Expands Development Collaboration with Gore
CHARLESTON, S.C., May 06, 2021 (GLOBE NEWSWIRE) — Today, Efferent Labs announces an expanded development…
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring | WHS 2021 Virtual Meeting
CANTON, Mass., May 06, 2021 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Eloxx Pharmaceuticals Reports First Quarter 2021 Financial and Operating Results and Provides Business Update
Acquisition of Zikani Therapeutics, Ribosomal Modulation Company; Combined Company Advancing Ribosomal RNA-Targeted Genetic Therapies Additional…
NextCure Reports First Quarter 2021 Financial Results
BELTSVILLE, Md., May 06, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical…
CORRECTING and REPLACING — Tricida Announces First Quarter 2021 Financial Results
Webcast Today at 4:30 pm Eastern Time SOUTH SAN FRANCISCO, May 06, 2021 (GLOBE NEWSWIRE)…
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021
Enrollment ongoing in three Cellectis-sponsored Phase 1 dose-escalation clinical studies BALLI-01 in r/r B-ALL patients,…
Certara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Guidance
PRINCETON, N.J., May 06, 2021 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader…
Nephros Announces Results for Quarter Ended March 31, 2021
Net Revenue of $2.7 Million; Highest First Quarter in Company History SOUTH ORANGE, NJ, May…
CytomX Therapeutics Announces First Quarter 2021 Financial Results and Provides Business Update
SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
Checkpoint Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate Highlights
NEW YORK, May 06, 2021 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a…
Aprea Therapeutics Reports First Quarter 2021 Financial Results and Provides Update on Business Operations
BOSTON, May 06, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused…
Translate Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
— Advanced infectious disease vaccine programs with Sanofi Pasteur through initiation of COVID-19 clinical trial…
Vor Reports First Quarter 2021 Financial Results and Provides Company Update
Health Canada clears the CTA for VOR33 clinical trial Vor to present on VOR33 manufacturing…
IGM Biosciences Announces First Quarter 2021 Financial Results and Provides Corporate Update
– Recommended Phase 2 Dose of IGM-2323 Expected in 2021 – – Initial Data from…
ORIC Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update
Lead program ORIC-101 on track for two initial Phase 1b data readouts in 2021 Three…
Crinetics Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
Paltusotine Phase 3 PATHFNDR program in acromegaly initiated in 2Q 2021 Phase 1 data for…